Marseille-Kliniken AG

EANS-News: Annual General Meeting of Marseille-Kliniken AG supports positive development of the company

  Corporate news transmitted by euro adhoc. The issuer/originator is solely
  responsible for the content of this announcement.
Annual & Special Corporate Meetings

Subtitle: - New supervisory board member Prof. Dr. Enderlein elected
- Expansion of the authorized capital to € 18.7 million
- At the request of the administration former board members were not relieved

Hamburg (euro adhoc) - 27 January 2012 - Today´s Annual General Meeting, located
at the company´s headquarter in Hamburg, approved all significant applications
of the administration with a majority of over 90 percent. This represented
approximately 65 percent of the share capital.

On administration´s recommendation, both former directors, Stefan Herzberg and
Dr. Thomas Klaue, were not relieved. Prof. Dr. Dietmar Enderlein was elected to
the Supervisory Board. The long-time expert in the health care industry is
following Mathias Kampmann, who retired on 17 January 2012.

The decision on the creation of new authorized capital was supported by the
major shareholder and the representatives of shareholder protection communities.
Overall, the meeting took place under the close observation of journalists and
numerous experts in health care.

"The decisions of our shareholders will create a reliable basis for our
operational success.", said Michael Thanheiser, chairman of the company.

Further inquiry note:
Christian Hillermann
Hillermann Consulting
Investor Relations for Marseille-Kliniken AG
Poststraße 14/16
20354 Hamburg
Tel.: +49-(0)40 / 320 279-10
Fax: +49-(0)40 / 320 279-114

end of announcement                               euro adhoc 

company:     Marseille-Kliniken AG
             Alte Jakobstraße 79/80
             D-10179 Berlin
phone:       +49 (0)30 246 32-400
FAX:         +49 (0)30 246 32-401
sector:      Pharmaceuticals
ISIN:        DE0007783003
indexes:     CDAX, Classic All Share, Prime All Share
stockmarkets: free trade: Berlin, Düsseldorf, Stuttgart, regulated dealing:
             Hamburg, regulated dealing/prime standard: Frankfurt 
language:   English

Weitere Meldungen: Marseille-Kliniken AG

Das könnte Sie auch interessieren: